Netlist Rally Memory Prices Could Trigger a Breakout
Memory prices are showing signs of life, and a small-cap memory company could ride the wave. This article explains wh...
Investing
This page offers a collection of 17 insightful articles on investing, covering strategies, market trends, and expert tips to enhance your financial journey.
15,957 articles
Vanguard Small-Cap Growth Growth: ETF Showdown 2026
Two Vanguard growth-focused funds sit on opposite ends of the market cap spectrum. This guide weighs small-cap opport...
Rocket Stock Gained 118%: Is It Time to Buy in 2025?
Rocket Lab’s stock jumped about 118% in the last year, but a big move doesn’t always mean a lasting uptrend. This art...
Here's Much More Upside in Palantir Stock, Analysts Say
Palantir has cooled off after a blazing run, but analysts say there's still meaningful upside. This guide breaks down...
Invesco Pharmaceuticals State Street ETFs: Which Is Better?
Two popular healthcare ETFs, PJP and XBI, offer very different paths to exposure. This guide breaks down the trade-of...
Massive YTD Leader: Nvidia Sets 2028 Price Outlook
Nvidia remains the marquee name in the 2026 AI stock rally, while AMD gains ground and Palantir stalls. Analysts sket...
Allstate’s Deep-Value Edge Tops Progressive in Q1 2026
Allstate beats on underwriting and returns capital, while Progressive shows growth but a steadier combined ratio. The...
Micron vs Intel: Which Volatile Memory Stock to Buy Now
Micron's memory leadership and AI-ready HBM4 shipments clash with Intel's restructuring effort and foundry bets. As A...
Super Micro Stock Just Collapses 29% in a Month
Super Micro Computer stock tumbled 29% in a month as Dell and HPE rally on AI growth. Analysts weigh whether investor...
S&P 500 Climbs This Year; Cash-Flow ETF Surges Ahead
The S&P 500 has posted a double-digit gain this year, even as a cash-flow focused ETF shows a different path, drawing...
Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Cramer: Cheap Still Cheaper — Salesforce Skeptics Persist
Jim Cramer remains wary of Salesforce as growth slows and CIOs shift budgets to less expensive software. He argues th...
Related Topics
#Stock Market (2704)
#AI (1894)
#Stock Analysis (1639)
#Personal Finance (1307)
#ETFs (1095)
#Earnings (1058)
#Retirement Planning (1056)
#Tech Stocks (1041)
#Portfolio Management (999)
#Stocks (995)
#Semiconductors (893)
#Markets (791)
#Market News (778)
#Portfolio Strategy (630)
#Market Trends (523)